CIK 0001069530 · Non-accelerated filer<br>Smaller reporting company
FILANA THERAPEUTICS, INC.
Sign in to watch- Ticker
- FLNA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 911911336
- Phone
- 512-501-2444
- Business address
- 6801 N CAPITAL OF TEXAS HIGHWAY, BUILDING 1; SUITE 300, AUSTIN, TX, 78731
- Former names
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Open-market buys, last 90 days
- $356,328
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$356,328. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-07-11 | SCHOENHARD GRANT Chief Scientific Officer | Option exercise · Common Stock | −128,693 | $4.54 | $584K | 1,001,880 |
| 2014-07-01 | FRIEDMANN NADAV Chief Operating Officer | Option exercise | +135,334 | $4.54 | $614K | 471,563 |
| 2014-07-01 | FRIEDMANN NADAV Chief Operating Officer | Shares withheld for taxes | −106,670 | $5.76 | $614K | 364,893 |
| 2014-07-01 | FRIEDMANN NADAV Chief Operating Officer | Option exercise · Common Stock | −135,334 | $4.54 | $614K | 3,454,535 |
| 2014-06-13 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualifying Stock Options (1) | +15,000 | $5.20 | $78K | 672,136 |
| 2014-06-13 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Options (1) | +15,000 | $5.20 | $78K | 646,398 |
| 2014-06-13 | Ramasastry Saira Director | Grant or award · Non-Qualifying Stock Options (1) | +15,000 | $5.20 | $78K | 155,000 |
| 2014-06-06 | RODDY PETER S chief Fianancial Officer | Grant or award · Stock Options(1) | +150,000 | $5.00 | $750K | 1,752,803 |
| 2014-06-06 | SCHOENHARD GRANT Chief Scientific Officer | Grant or award · Stock Options(1) | +70,000 | $5.00 | $350K | 1,130,573 |
| 2014-06-06 | FRIEDMANN NADAV Chief Operating Officer | Grant or award · Stock Options(1) | +300,000 | $5.00 | $1.5M | 3,589,869 |
| 2014-06-06 | BARBIER REMI CEO, Chairman of the Board | Grant or award · Stock Options(1) | +600,000 | $5.00 | $3.0M | 5,553,241 |
| 2014-05-27 | GUSSIN ROBERT Z Director | Option exercise | +42,897 | $4.49 | $193K | 66,429 |
| 2014-05-27 | GUSSIN ROBERT Z Director | Shares withheld for taxes | −39,069 | $4.93 | $193K | 27,360 |
| 2014-05-27 | GUSSIN ROBERT Z Director | Option exercise · Common Stock | −42,897 | $4.49 | $193K | 657,136 |
| 2014-05-16 | SCANNON PATRICK J MD PHD Director | Grant or award · Non-Qualifying Stock Options (1) | +50,000 | $4.59 | $230K | 479,128 |
| 2014-05-16 | Ramasastry Saira Director | Grant or award · Non-Qualifying Stock Options (1) | +50,000 | $4.59 | $230K | 140,000 |
| 2014-05-16 | ROBERTSON SANFORD Director | Grant or award · Non-Qualifying Stock Options (1) | +50,000 | $4.59 | $230K | 631,398 |
| 2014-05-16 | O DONNELL MICHAEL J Director | Grant or award · Non-Qualifying Stock Options (1) | +50,000 | $4.59 | $230K | 422,750 |
| 2014-05-16 | GUSSIN ROBERT Z Director | Grant or award · Non-Qualifying Stock Options (1) | +50,000 | $4.59 | $230K | 700,033 |
| 2014-04-09 | FRIEDMANN NADAV Chief Operating Officer | Option exercise | +122,054 | $4.54 | $554K | 434,304 |
Page 14 of 17 · 324 trades